Skip to content

Day 2 Parallel Sessions

Thursday, April 10, 2025   

Session TimeRoom TitleOrganizers
S1A10:15-11:45amTrinity A/BHonoring Dr. Richard SimonMarlina Nasution, PhD (AskBio)
Shuyen Ho, PhD (Consultant)
S1B10:15-11:45amTrinity CCovariate Adjustment in Clinical TrialsRakhi Kilaru, MS, MBA (PPD clinical research business of Thermo Fisher Scientific)
Yeh-Fong Chen, PhD (FDA)
S1C10:15-11:45amTrinity DStatistical Methods in Restricted Mean Survival TimeHwanhee Hong, PhD (Duke)
Kaiyuan Hua, PhD (Duke)
S1D10:15-11:45amTrustees 1/2Recent Advances in Computing, Optimization, and Causal Inference for Adaptive Clinical TrialsBrad Carlin, PhD (PhaseV Trials)
S2A1:30-3:00pmTrinity A/BInnovative Statistical Methods in Biomarker-Assisted Drug DevelopmentShibing Deng, PhD (Pfizer)
S2B1:30-3:00pmTrinity CQuantitative Leadership and Innovation to Accelerate Drug Development: Insights from Leaders in Statistics & Data ScienceCharlotte Baidoo, MMath (Bristol Myers Squibb)
Mariann Micsinai-Balan, PhD (Bristol Myers Squibb)
S2C1:30-3:00pmTrinity DAdvances in Use of External and Literature Data for Clinical Development and Surveillance: Bayesian, AI/ML and MoreJian Zhu, PhD (Servier)
Cindy Gao, PhD (FDA)
S2D1:30-3:00pmTrustees 1/2Pediatric Drug Development: Emerging Innovations and Future DirectionsJingjing Ye, PhD (BeiGene)
Freda Cooner (FDA)
S3A3:15-5:00pmTrinity A/BJourney to Dose Optimization in Oncology- Challenges and Learning through Designs and ApplicationsJames Rogers, PhD (Metrum Research Group)
Nicole Li, PhD (BeiGene)
S3B3:15-5:00pmTrinity CPoster Lightening TalksRoland Matsouaka, PhD (Duke)
Lisa Wruck, PhD (Duke)
S3C3:15-5:00pmTrinity DRecent Advances in Statistical Methodology for Biosimilar and Bioequivalence StudiesFairouz Makhlouf, PhD (FDA)
S3D3:15-5:00pmTrustees 1/2Challenges and Opportunities of ML/AL in Drug DevelopmentZhaoyang Teng, PhD (Servier)
Wenqiong Xue, PhD (Boehringer Ingelheim)